Analysis of clinical characteristics and influencing factors of children with short stature
-
摘要:
目的 了解矮小症的临床特点,并分析其影响因素,为临床防治矮小症提供理论依据。 方法 选取2021年8月—2023年3月在丽水市中医院儿科就诊的矮小症患儿122例,并选取同期发育正常的儿童124例作为对照组,比较2组临床资料,分析矮小症临床特点及影响因素。 结果 观察组体质量、BMI、骨龄和骨龄指数(BAI)分别为(27.25±4.23)kg,17.52±2.65、(9.61±1.72)岁、0.91±0.25,对照组分别为(39.36±4.62)kg,20.85±2.72、(12.89±1.68)岁、1.26±0.29,观察组均明显低于对照组(P<0.05);多因素logistic回归分析显示维生素D缺乏(OR=4.608)、伴有基础疾病(OR=2.529)、家族矮小史(OR=1.931)、父亲身高<160 cm(OR=3.089)、母亲身高<150 cm(OR=3.861)、出生半年内行混合或牛奶喂养(OR=1.876)、家庭不和睦(OR=1.966)、每周弹跳运动较少(OR=4.898)、睡眠时长<10 h/d(OR=6.651)均是影响矮小症儿童发病的独立危险因素。 结论 矮小症儿童的体质量和骨龄等指标均低于正常身高儿童,矮小症的发病受环境和遗传等多种因素影响,临床应根据上述高危因素采取干预措施以降低矮小症的发生风险。 Abstract:Objective To understand the clinical characteristics of nanosomia and analyze its influencing factors, so as to provide theoretical basis for the prevention and treatment of short stature. Methods A total of 122 children with nanosomia in Lishui Hospital of Traditional Chinese Medicine from August 2021 to March 2023 were selected as the research object, and 124 children with normal development during the same period were selected as the control group. Clinical data of the two groups were compared, and the clinical characteristics and influencing factors of nanosomia were analyzed. Results The body weight, BMI, bone age, and bone age index (BAI) of the observation group were (27.25±4.23) kg, 17.52±2.65, (9.61±1.72) years, and 0.91±0.25, respectively, while the control group were (39.36±4.62) kg, 20.85±2.72, (12.89±1.68) years, and 1.26±0.29, respectively. The observation group were significantly lower than those of the control group (P < 0.05). Multivariate logistic regression analysis showed vitamin D deficiency (OR=4.608), accompanied by basic diseases (OR=2.529), family history of short stature (OR=1.931), paternal height less than 160 cm (OR=3.089), maternal height less than 150 cm (OR=3.861), mixed or breast-fed within six months of birth (OR=1.876), family discord (OR=1.966), less bounce exercise per week (OR=4.898), and sleep duration less than 10 h/d (OR=6.651) were independent risk factors affecting the occurrence of nanosomia in children. Conclusion The weight and bone age of children with nanosomia are lower than those of normal children. The occurrence of nanosomia is affected by many factors such as environment and heredity. Clinical intervention measures should be taken according to the above-mentioned high-risk factors to reduce the risk of nanosomia. -
Key words:
- Short stature /
- Children /
- Clinical characteristics /
- Influencing factors
-
表 1 矮小症患儿组与对照组临床特点比较(x ±s)
Table 1. Comparison of clinical characteristics between nanosomia group and control group in children (x ±s)
组别 例数 体质量(kg) BMI 骨龄(岁) BAI 观察组 122 27.25±4.23 17.52±2.65 9.61±1.72 0.91±0.25 对照组 124 39.36±4.62 20.85±2.72 12.89±1.68 1.26±0.29 t值 21.433 9.724 15.131 10.132 P值 <0.001 <0.001 <0.001 <0.001 表 2 矮小症患儿组与对照组临床资料比较
Table 2. Comparison of clinical data between nanosomia group and control group in children
组别 例数 年龄(x ±s,岁) 性别[例(%)] 添加辅食时间[例(%)] 维生素D水平[例(%)] 母亲孕期情况[例(%)] 出生胎龄[例(%)] 男 女 ≥6个月 <6个月 正常 缺乏 健康 患病 足月 早产 观察组 122 7.25±1.73 63(51.64) 59(48.36) 89(72.95) 33(27.05) 51(41.80) 71(58.20) 109(89.34) 13(10.66) 108(88.52) 14(11.48) 对照组 124 7.29±1.82 71(57.26) 53(42.74) 92(74.19) 32(25.81) 89(71.77) 35(28.23) 113(91.13) 11(8.87) 112(90.32) 12(9.68) 统计量 0.135a 0.783b 0.049b 22.526b 0.222b 0.210b P值 0.893 0.376 0.825 <0.001 0.637 0.647 组别 例数 生产方式[例(%)] 出生季节[例(%)] 伴有基础疾病[例(%)] 家族矮小史[例(%)] 父亲身高[例(%)] 母亲身高[例(%)] 剖宫产 顺产 春夏 秋冬 是 否 有 无 ≥160 cm <160 cm ≥150 cm <150 cm 观察组 122 68(55.74) 54(44.26) 75(61.48) 47(38.52) 26(21.31) 96(78.69) 18(14.75) 104(85.25) 74(60.66) 48(39.34) 67(54.92) 55(45.08) 对照组 124 71(57.26) 53(42.74) 81(65.32) 43(34.68) 11(8.87) 113(91.13) 8(6.45) 116(93.55) 95(76.61) 29(23.39) 88(70.97) 36(29.03) 统计量 0.058b 0.392b 7.448b 4.485b 7.282b 6.796b P值 0.810 0.531 0.006 0.034 0.007 0.009 组别 例数 出生半年内喂养方式[例(%)] 家庭关系[例(%)] 每周弹跳运动[例(%)] 睡眠时长[例(%)] 每日补钙[例(%)] 纯母乳 混合或牛奶 不和睦 和睦 充足 较少 ≥10 h/d <10 h/d 充足 不足 观察组 122 63(51.64) 59(48.36) 15(12.30) 107(87.70) 43(35.25) 79(64.75) 56(45.90) 66(54.10) 53(43.44) 69(56.56) 对照组 124 81(65.32) 43(34.68) 6(4.84) 118(95.16) 71(57.26) 53(42.74) 95(76.61) 29(23.39) 71(57.26) 53(42.74) 统计量 4.744b 4.379b 11.983b 24.469b 4.695b P值 0.029 0.036 <0.001 <0.001 0.030 注:a为t值,b为χ2值。 表 3 变量赋值情况
Table 3. Variable assignment
变量 赋值方法 维生素D水平 缺乏=0,正常=1 伴有基础疾病 否=0,是=1 家族性矮小史 无=0,有=1 父亲身高 ≥160 cm=0,<160 cm=1 母亲身高 ≥150 cm=0,<150 cm=1 出生半年内喂养方式 纯母乳=0,混合或牛奶=1 家庭关系 不和睦=0,和睦=1 每周弹跳运动 充足=0,较少=1 睡眠时长 ≥10 h/d=0,<10 h/d=1 每日补钙 充足=0,不足=1 矮小症 否=0,是=1 表 4 影响矮小症发病的多因素logistic回归分析
Table 4. Multivariate logistic regression analysis of factors influencing the incidence of nanosomia
项目 B SE Waldχ2 P值 OR值 95%CI 维生素D缺乏 1.528 0.726 13.853 <0.001 4.608 1.111~19.118 伴有基础疾病 0.928 0.412 6.553 0.010 2.529 1.128~5.671 家族矮小史 0.658 0.327 3.891 0.049 1.931 1.017~3.665 父亲身高<160 cm 1.128 0.453 7.529 0.006 3.089 1.271~7.506 母亲身高<150 cm 1.351 0.556 8.989 0.003 3.861 1.299~1.479 出生半年内行混合或牛奶喂养 0.629 0.319 4.326 0.038 1.876 1.004~3.505 家庭不和睦 0.676 0.315 4.728 0.030 1.966 1.060~3.645 每周弹跳运动较少 1.589 0.625 10.792 0.001 4.898 1.439~16.672 睡眠时长<10 h/d 1.895 0.826 15.997 <0.001 6.651 1.318~33.569 每日补钙 0.398 0.351 2.256 0.133 1.489 0.748~2.962 -
[1] 何轶群, 郭莉, 张忆聪, 等. 605例身材矮小症患儿的染色体核型分析[J]. 中华医学遗传学杂志, 2020, 37(11): 1301-1303. doi: 10.3760/cma.j.cn511374-20191017-00534HE Y Q, GUO L, ZHANG Y C, et al. Karyotype analysis of 605 children with short stature[J]. Chinese Journal of Medical Genetics, 2020, 37(11): 1301-1303. doi: 10.3760/cma.j.cn511374-20191017-00534 [2] 北京首都儿科研究所. 中国儿童生长标准2019版专家解读[J]. 教育生物学杂志, 2019, 7(4): 231. https://www.cnki.com.cn/Article/CJFDTOTAL-BIOM201904009.htmBeijing Children's Hospital affiliated to Capital Medical University. China Child growth standards 2019 edition expert interpretation[J]. Journal of Bio-education, 2019, 7(4): 231. https://www.cnki.com.cn/Article/CJFDTOTAL-BIOM201904009.htm [3] 闫培培, 杨玲玲, 党晓丽. 2015—2017年郑州某医院矮小症患儿焦虑抑郁状况调查[J]. 预防医学论坛, 2019, 25(1): 39-41. https://www.cnki.com.cn/Article/CJFDTOTAL-YXWX201901015.htmYAN P P, YANG L L, DANG X L. Analysis on anxiety and depression status among children with dwarfism in a hospital, Zhengzhou, 2015—2017[J]. Preventive medicine tribune, 2019, 25(1): 39-41. https://www.cnki.com.cn/Article/CJFDTOTAL-YXWX201901015.htm [4] 段利侠, 李婷, 牛忠鹏. 认知行为疗法在矮小症儿童治疗中的应用及对儿童SDS、SAS评分的影响[J]. 临床与病理杂志, 2021, 41(11): 2638-2643. doi: 10.3978/j.issn.2095-6959.2021.11.023DUAN L X, LI T, NIU Z P. Application of cognitive-behavioral therapy in the treatment of children with short stature and its effects on children's SDS and SAS scores[J]. Journal of Clinical and Pathological Research, 2021, 41(11): 2638-2643. doi: 10.3978/j.issn.2095-6959.2021.11.023 [5] 陈倩, 杨亭, 张萱, 等. 生长激素治疗儿童特发性矮小症疗效分析[J]. 儿科药学杂志, 2019, 25(6): 6-9. https://www.cnki.com.cn/Article/CJFDTOTAL-EKYX201906004.htmCHEN Q, YANG T, ZHANG X, et al. Analysis of therapeutic effect of growth hormone on idiopathic nanosomia in children[J]. Journal of Pediatric Pharmacy, 2019, 25(6): 6-9. https://www.cnki.com.cn/Article/CJFDTOTAL-EKYX201906004.htm [6] 王卫平, 孙锟, 常立文. 儿科学[M]. 9版. 北京: 人民卫生出版社, 2018: 395-399.WANG W P, SUN K, CHANG L W. Pediatrics[M]. 9th Ed. Beijing: People'S Medical Publishing House, 2018: 395-399. [7] 秦锐. 中国儿童钙营养专家共识(2019年版)[J]. 中国妇幼健康研究, 2019, 30(3): 262-269. doi: 10.3969/j.issn.1673-5293.2019.03.001QIN R. Expert Consensus on Calcium Nutrition for Children in China (2019 edition)[J]. Chinese Journal of Woman and Child Health Researc, 2019, 30(3): 262-269. doi: 10.3969/j.issn.1673-5293.2019.03.001 [8] 李翠, 朱莉, 许宏苑. 矮小症74例病因分析[J]. 中国乡村医药, 2022, 29(15): 39-40. doi: 10.3969/j.issn.1006-5180.2022.15.016LI C, ZHU L, XU H Y. Etiological analysis of 74 cases of nanosomia[J]. Zhongguo Xiangcun Yiyao, 2022, 29(15): 39-40. doi: 10.3969/j.issn.1006-5180.2022.15.016 [9] 鲁燕飞, 金平. 矮小症患儿血清胰岛素样生长因子-1, 25-羟维生素D水平及临床特征分析[J]. 中国妇幼保健, 2021, 36(11): 2580-2582. https://www.cnki.com.cn/Article/CJFDTOTAL-ZFYB202111044.htmLU Y F, JIN P. Analysis of serum insulin-like growth factor-1 25 hydroxyvitamin D levels and clinical characteristics in children with nanosomia[J]. Maternal and Child Health Care of China, 2021, 36(11): 2580-2582. https://www.cnki.com.cn/Article/CJFDTOTAL-ZFYB202111044.htm [10] 王锐, 陈琦, 谢雄. 维生素D联合重组人生长激素对特发性矮小症的治疗效果[J]. 实用临床医药杂志, 2023, 27(11): 59-63. doi: 10.7619/jcmp.20223216WANG R, CHEN Q, XIE X. Therapeutic effect of vitamin D combined with recombinant human growth hormone on idiopathic nanosomia[J]. Journal of Clinical Medicine in Practice, 2023, 27(11): 59-63. doi: 10.7619/jcmp.20223216 [11] 刘冲, 云惠聪, 张秀兰, 等. 内蒙古自治区3~18岁儿童体格发育调查[J]. 中华全科医学, 2022, 20(2): 327-331. doi: 10.16766/j.cnki.issn.1674-4152.002344LIU C, YUN H C, ZHANG X L, et al. Physical development of children aged 3—18 years in Inner Mongolia Autonomous Region[J]. Chinese Journal of General Practice, 2022, 20(2): 327-331. doi: 10.16766/j.cnki.issn.1674-4152.002344 [12] 梁小红, 谭迪, 简杨湄. 特发性矮小症患儿血清25(OH)D、IGF-1水平与体质量的相关性[J]. 海南医学, 2020, 31(7): 841-844. doi: 10.3969/j.issn.1003-6350.2020.07.008LIANG X H, TAN D, JIAN Y M. Correlation between serum 25 (OH)D, IGF-1, and body weight in children with idiopathic dwarfism[J]. Hainan Medical Journal, 2020, 31(7): 841-844. doi: 10.3969/j.issn.1003-6350.2020.07.008 [13] 王维, 陈洋, 唐雨莉, 等. 矮小症儿童临床特征及相关危险因素分析[J]. 中国中西医结合儿科学, 2023, 15(2): 133-137. doi: 10.3969/j.issn.1674-3865.2023.02.009WANG W, CHEN Y, TANG Y L, et al. Analysis of clinical features and related risk factors in children with short stature[J]. Chinese Pediatrics of Integrated Traditional and Western Medicine, 2023, 15(2): 133-137. doi: 10.3969/j.issn.1674-3865.2023.02.009 [14] 杜娟, 付志平, 王秀芳. 安阳市北关区7~13周岁儿童矮小症的流行病学调查及预测模型构建[J]. 中国卫生工程学, 2022, 21(5): 744-747. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGWX202205014.htmDU J, FU Z P, WANG X F. Epidemiological investigation and prediction model construction of nanosomia in children aged 7-13 years in Beiguan District, Anyang City[J]. Chinese Journal of Public Health Engineering, 2022, 21(5): 744-747. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGWX202205014.htm [15] 胡孝成. 母乳喂养对低出生体质量儿喂养耐受及胃肠道恢复的影响[J]. 当代医学, 2021, 27(20): 177-178. doi: 10.3969/j.issn.1009-4393.2021.20.078HU X C. The effect of breastfeeding on feeding tolerance and gastrointestinal recovery in low birth weight infants[J]. Contemporary Medicine, 2021, 27(20): 177-178. doi: 10.3969/j.issn.1009-4393.2021.20.078 [16] 李月华, 谢微微, 段秀珍. 母乳和配方乳喂养对极低出生体质量早产儿生长发育的影响对比研究[J]. 中国妇幼保健, 2021, 36(15): 3517-3521. https://www.cnki.com.cn/Article/CJFDTOTAL-ZFYB202115033.htmLI Y H, XIE W W, DUAN X Z. Comparative study on the effects of breast milk and formula feeding on the growth and development of very low birth weight premature infants[J]. Maternal and Child Health Care of China, 2021, 36(15): 3517-3521. https://www.cnki.com.cn/Article/CJFDTOTAL-ZFYB202115033.htm [17] 颜丽娟, 龚岱, 文湘兰, 等. 株洲地区6~12岁儿童矮小症患病情况及其影响因素分析[J]. 教育生物学杂志, 2022, 10(4): 292-296. doi: 10.3969/j.issn.2095-4301.2022.04.007YAN L J, GONG D, WEN X L, et al. Analysis of condition and influencing factors of short stature in children aged 6-12 in Zhuzhou area[J]. Journal of Bio-education, 2022, 10(4): 292-296. doi: 10.3969/j.issn.2095-4301.2022.04.007 [18] 孙凤平, 崔伟锋, 李宁宁, 等. 运动联合补中助长颗粒治疗特发性矮小症临床研究[J]. 新中医, 2020, 52(23): 69-72. https://www.cnki.com.cn/Article/CJFDTOTAL-REND202023020.htmSUN F P, CUI W F, LI N N, et al. Clinical Study on Exercise Combined with Buzhong Zhuzhang Granules for Idiopathic Short Statue[J]. Journal of New Chinese Medicine, 2020, 52(23): 69-72. https://www.cnki.com.cn/Article/CJFDTOTAL-REND202023020.htm [19] JI J J, YANG Y W, LIN Y, et al. The correlation between growth hormone receptor (GHR) polymorphism and obstructive sleep apnea syndrome among the Han and Hani population in China[J]. Neurol Sci, 2018, 39(7): 1211-1216. doi: 10.1007/s10072-018-3326-1 [20] 许露, 肖延风, 王亚萍, 等. 身材矮小儿童睡眠饮食和行为问题的病例对照研究[J]. 中国儿童保健杂志, 2020, 28(6): 664-668. https://www.cnki.com.cn/Article/CJFDTOTAL-ERTO202006017.htmXU L, XIAO Y F, WANG Y P, et al. A case-control study of sleep eating and behavioral problems in short stature children[J]. Chinese Journal of Child Health Care, 2020, 28(6): 664-668. https://www.cnki.com.cn/Article/CJFDTOTAL-ERTO202006017.htm -

计量
- 文章访问数: 164
- HTML全文浏览量: 56
- PDF下载量: 6
- 被引次数: 0